Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | NASDAQ | Biotechnology | $35.34B | $319.06 | -0.55% | $318.03M | 6,381.20x | 0.85 | Cayman Islands | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $9.26B | $87.99 | 0.99% | $65.98M | 87.99x | 0.30 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $222.97B | $50.18 | -0.22% | $24.81B | 13.95x | 2.02 | Denmark | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | $52.52B | $397.55 | -3.65% | $151.92M | 1,282.42x | 19.74 | United States | ||
| ZVRA | ZEVRA THERAPEUTICS INC | NASDAQ | Biotechnology | $468.96M | $8.33 | -0.72% | $67.21M | 17.35x | 1.03 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $3.15B | $41.59 | 1.41% | $53.58M | 84.88x | 0.33 | Bermuda | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $20.10B | $31.31 | -3.07% | $2.00B | 13.36x | 0.22 | Denmark | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $53.58B | $877.94 | -1.30% | $811.30M | 35.08x | 0.18 | Belgium | ||
| LGND | LIGAND PHARMACEUTICALS INC | NASDAQ | Biotechnology | $3.73B | $189.55 | 3.51% | $103.01M | 82.06x | 0.55 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.85B | $36.54 | -2.27% | $29.31M | 140.54x | 0.41 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.12B | $58.51 | -2.90% | $220.90M | 117.02x | 0.29 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $22.16B | $38.39 | -1.08% | $1.04B | 21.81x | 1.01 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $7.09B | $244.65 | -0.86% | $193.29M | 35.46x | 0.09 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $3.39B | $42.84 | 1.47% | $57.00M | 109.85x | 0.09 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $740.80M | $7.69 | -2.29% | $13.23M | 109.86x | 0.22 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $905.29M | $11.49 | -2.13% | $112.26M | 5.06x | 1.01 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.09B | $15.85 | -0.19% | $103.52M | 27.33x | 0.44 | Canada | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.24B | $53.31 | 0.60% | $772.70M | 19.60x | 0.26 | United States | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | NYSEMKT | Biotechnology | $143.95M | $1.79 | -2.19% | $8.87M | 25.57x | 0.56 | Israel | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $7.32B | $62.21 | 0.50% | $845.48M | 12.72x | 3.41 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.96B | $40.88 | -1.23% | $927.60M | 16.62x | 0.31 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $2.33B | $40.51 | 2.32% | $269.64M | 12.54x | 0.45 | United States | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.82B | $5.94 | 2.24% | $73.18M | 59.40x | -12.10 | United States | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $18.73B | $95.41 | -0.72% | $1.68B | 15.80x | 0.36 | United States | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.54B | $20.63 | 0.05% | $214.76M | 10.92x | 0.42 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $114.69B | $452.04 | 1.37% | $4.66B | 31.59x | 0.44 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $4.71B | $19.78 | -2.94% | $172.13M | 22.48x | 0.32 | United States | ||
| NAGE | NIAGEN BIOSCIENCE INC | NASDAQ | Biotechnology | $520.34M | $6.52 | -1.66% | $22.69M | 24.15x | 0.39 | United States | ||
| UTHR | UNITED THERAPEUTICS CORP | NASDAQ | Biotechnology | $21.27B | $493.99 | 1.12% | $1.77B | 17.35x | 0.12 | United States | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.90B | $23.62 | 2.96% | $323.88M | 13.20x | 0.14 | United States | ||
| REGN | REGENERON PHARMACEUTICALS INC | NASDAQ | Biotechnology | $77.91B | $741.29 | -0.74% | $5.71B | 17.06x | 0.30 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.07B | $7.22 | 0.84% | $69.21M | 25.79x | 0.34 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.